Cash Transfers for Child Neurodevelopment
Trial Summary
What is the purpose of this trial?
This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT. Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol. Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Supplemental cash transfer for child neurodevelopment?
Research shows that cash transfer programs can improve child health and nutrition by providing financial support to families, which helps them access better food and healthcare. These programs have been associated with positive outcomes like improved child growth and reduced malnutrition in low- and middle-income countries.12345
How does the treatment of supplemental cash transfer differ from other treatments for child neurodevelopment?
Supplemental cash transfers are unique because they provide financial support to families, which can improve child health and development by enhancing access to better nutrition, healthcare, and educational resources. Unlike traditional medical treatments, this approach addresses the socio-economic factors that can influence a child's development.12356
Research Team
Cristiane Duarte, PhD
Principal Investigator
New York State Psychiatric Institute
Andrea Jackowsi, PhD
Principal Investigator
Federal University of São Paulo
Jonathan Posner, MD
Principal Investigator
Duke University
Tenneill Murray, MPH
Principal Investigator
New York State Psychiatric Institute
Eligibility Criteria
This trial is for mothers aged 23-45 in Brazil with at least one child aged 7-10, already receiving Auxilio Brasil cash transfers. They must be able to give consent and have a willingness to participate along with their child.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments including MRI scans, biospecimen collection, and behavioral evaluations
Intervention
Families receive either high or low supplemental cash transfers for 24 months
Follow-up
Participants are monitored for changes in neurodevelopmental and mental health outcomes post-intervention
Treatment Details
Interventions
- Supplemental cash transfer
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York State Psychiatric Institute
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator